BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7624601)

  • 1. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
    Retina; 1995; 15(2):134-40. PubMed ID: 7624601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorophotometry in juvenile-onset diabetes: long-term follow-up.
    Krupin T; Waltman SR
    Jpn J Ophthalmol; 1985; 29(2):139-45. PubMed ID: 4046222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new method in the analysis of vitreous fluorophotometry. Results in early diabetic retinopathy].
    Roy MS; Bungay P; Collier B; Bonner R
    Ophtalmologie; 1989; 3(3):214-6. PubMed ID: 2641114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-retina barrier permeability in diabetes during acute ACE-inhibition.
    Engler CB; Parving HH; Mathiesen ER; Larsen M; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1991 Oct; 69(5):581-5. PubMed ID: 1776410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the permeability of the blood-retinal barrier in normal individuals.
    Oguro Y; Tsukahara Y; Saito I; Kondo T
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):969-76. PubMed ID: 4008211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of intraocular gases on rabbit blood-retinal barrier permeability.
    Green K; Slagle T; Cheeks L; Norman BC
    Lens Eye Toxic Res; 1992; 9(1):67-76. PubMed ID: 1599908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of therapy on vitreous fluorophotometry in diabetes mellitus.
    Waltman SR; Krupin T; Singer P; Becker B
    Trans Ophthalmol Soc U K (1962); 1979 Apr; 99(1):8-9. PubMed ID: 297386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of permeability in blood-retinal barrier.
    Kojima M; Yoshida A; Ishiko S; Tanaka K
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):419-27. PubMed ID: 2227794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
    Parving HH; Larsen M; Hommel E; Lund-Andersen H
    Diabetologia; 1989 Jul; 32(7):440-4. PubMed ID: 2680698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
    Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
    Retina; 1987; 7(3):170-6. PubMed ID: 3423432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of early retinal changes in diabetes by vitreous fluorophotometry.
    Cunha-Vaz JG; Fonseca JR; Abreu JF; Ruas MA
    Diabetes; 1979 Jan; 28(1):16-9. PubMed ID: 759246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surveillance using vitreo-fluoro-photometry of diabetics treated with an insulin pump, without or with minimal retinopathy. Results after 3 years].
    Bordat B; Misse P; Zaluski S; Rouault R; Mirouze J
    J Fr Ophtalmol; 1989; 12(6-7):421-5. PubMed ID: 2636237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy].
    Bordat B; Guirgis IR; Manderscheid JC
    J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
    Knudsen LL; Olsen T; Nielsen-Kudsk F
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
    Leite EB; Mota MC; de Abreu JR; Cunha-Vaz JG
    Int Ophthalmol; 1990 Mar; 14(2):81-8. PubMed ID: 2187006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes.
    Chahal PS; Chowienczyk PJ; Kohner EM
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):977-82. PubMed ID: 4008212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative vitreous fluorophotometry applying a mathematical model of the eye.
    Lund-Andersen H; Krogsaa B; la Cour M; Larsen J
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy.
    Yoshida A; Kojima M; Ogasawara H; Ishiko S
    Ophthalmology; 1991 Aug; 98(8):1266-71. PubMed ID: 1923365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The blood-retinal barrier in chloroquine retinopathy.
    Raines MF; Bhargava SK; Rosen ES
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.